Grant Application Policies

Arthritis Grant Application Policies

Arthritis National Research Foundation’s Board of Directors and Scientific Advisory Board are committed to providing uninterrupted research in the search for new therapies and a cure. The results will mean improved treatment for the estimated 54 million Americans and 300,000 children who suffer from some form of arthritis.

Grant Policies


  • The Scientific Advisory Board and the Board of Directors review grant proposals annually.
  • Clinical and basic studies will be considered. Clinical studies should have a translational component that helps reveal the underlying mechanisms or response to therapy.
  • Investigators must possess either a M.D. and/or Ph.D. degree or equivalent, affiliated with a qualified, non-profit institution.
  • Preference will be given to senior post-doctoral investigators transitioning to independent investigator status and new assistant professors.
  • Applicants may not have (or ever had) an NIH R01 grant or equivalent. (“Or equivalent” is defined as receipt of an NIH K08 grant plus other support totaling more than $250,000 per year.) Please do not apply if you’ve had an NIH R01 or equivalent support.
  • Grants are awarded for one year. First-year recipients may submit a second-year application during the year of their award. See guidelines for details.
  • Grants are awarded up to $100,000. Partial funding may be awarded if grantee has documentation that the remainder of the funding for proposed research has been acquired.
  • Salaries, supplies and equipment directly related to the proposed study are included in funding. Overhead or indirect costs will not be funded.
  • 10-20 grants funded routinely per year.
  • Additional administrative review may be rendered to determine priority for funding when multiple proposals are received from a single laboratory, Division or Department.
  • Applicants need not be U.S. citizens; however, all work must be done at a qualified U.S. nonprofit research institution.


*Applications not in strict compliance with stated policies and guidelines will be subject to administrative inactivation.

No-Cost Time Extensions on Arthritis National Research Foundation Grant Awards


No-cost extensions may be approved for Arthritis National Research Foundation grant awards, not to exceed three months. Requests from current grant recipients must be submitted in writing (e-mail acceptable).

Transfer of Arthritis National Research Foundation Grant Awards


If an investigator changes institutions during the grant award period, the Arthritis National Research Foundation requests the following:


  • A letter from the new institution, preferably the head of the department, stating that the investigator will be working on the same project and have the laboratory facilities and time available to do so. The letter should indicate the start date of the investigator in the new environment, as well as the contact information, address, e-mail, phone for disbursement of the remaining Arthritis National Research Foundation grant funds. The letter must be co-signed by the responsible business/grants management official of the new institution.


  • The original institution is responsible for sending any unused funds, prorated depending on the date, to the Arthritis National Research Foundation. We will then forward a new check for the unused funds to the new institution.

How to Apply


The Grant Application Requirements details are available online. Click the text or the link below. A standard cover sheet and budget page are required and provided in this section of the site. You will also be asked to setup an account so that your completed application may also be uploaded to our secure online system.


The Arthritis National Research Foundation (ANRF) is dedicated to funding highly qualified investigators associated with major research institutes, universities and hospitals throughout the country who are seeking to discover new knowledge for the prevention, treatment and cure of arthritis and other rheumatic diseases. We look forward to your interest and applications.